[{"Assets_0_Q1_USD":37624300000.0,"CommonStockDividendsPerShareCashPaid_1_Q1_USD":0.52,"EarningsPerShareBasic_1_Q1_USD":-0.1,"EarningsPerShareDiluted_1_Q1_USD":-0.1,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":339900000.0,"NetIncomeLossConverted_1_Q1_USD":-110800000.0,"RevenuesConverted_1_Q1_USD":5228300000.0,"StockholdersEquity_0_Q1_USD":14031000000.0,"StockholdersEquityConverted_0_Q1_USD":14103700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1056300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1056300000.0,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170501"}]